nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Cladribine—RRM2—uterine cancer	0.0176	1	CrCbGaD
Telbivudine—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00489	0.00498	CcSEcCtD
Telbivudine—Mediastinal disorder—Progesterone—uterine cancer	0.00486	0.00495	CcSEcCtD
Telbivudine—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00485	0.00494	CcSEcCtD
Telbivudine—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.0048	0.00489	CcSEcCtD
Telbivudine—Sepsis—Etoposide—uterine cancer	0.00477	0.00485	CcSEcCtD
Telbivudine—Malnutrition—Progesterone—uterine cancer	0.0047	0.00478	CcSEcCtD
Telbivudine—Back pain—Progesterone—uterine cancer	0.00454	0.00462	CcSEcCtD
Telbivudine—Muscle spasms—Progesterone—uterine cancer	0.00452	0.0046	CcSEcCtD
Telbivudine—Neutropenia—Dactinomycin—uterine cancer	0.00446	0.00453	CcSEcCtD
Telbivudine—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00441	0.00448	CcSEcCtD
Telbivudine—Ill-defined disorder—Progesterone—uterine cancer	0.00436	0.00444	CcSEcCtD
Telbivudine—Hepatomegaly—Epirubicin—uterine cancer	0.00435	0.00443	CcSEcCtD
Telbivudine—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00426	0.00433	CcSEcCtD
Telbivudine—Malaise—Progesterone—uterine cancer	0.00424	0.00431	CcSEcCtD
Telbivudine—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00417	0.00424	CcSEcCtD
Telbivudine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00412	0.00419	CcSEcCtD
Telbivudine—Cough—Progesterone—uterine cancer	0.0041	0.00417	CcSEcCtD
Telbivudine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00409	0.00416	CcSEcCtD
Telbivudine—Hepatomegaly—Doxorubicin—uterine cancer	0.00403	0.0041	CcSEcCtD
Telbivudine—Chest pain—Progesterone—uterine cancer	0.004	0.00407	CcSEcCtD
Telbivudine—Myalgia—Progesterone—uterine cancer	0.004	0.00407	CcSEcCtD
Telbivudine—Arthralgia—Progesterone—uterine cancer	0.004	0.00407	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00397	0.00404	CcSEcCtD
Telbivudine—Discomfort—Progesterone—uterine cancer	0.00395	0.00402	CcSEcCtD
Telbivudine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00395	0.00402	CcSEcCtD
Telbivudine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00384	0.00391	CcSEcCtD
Telbivudine—Hepatitis—Dactinomycin—uterine cancer	0.00381	0.00388	CcSEcCtD
Telbivudine—Pharyngitis—Dactinomycin—uterine cancer	0.00378	0.00385	CcSEcCtD
Telbivudine—Nervous system disorder—Progesterone—uterine cancer	0.00376	0.00383	CcSEcCtD
Telbivudine—Skin disorder—Progesterone—uterine cancer	0.00372	0.00379	CcSEcCtD
Telbivudine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00362	0.00369	CcSEcCtD
Telbivudine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00362	0.00369	CcSEcCtD
Telbivudine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00362	0.00369	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.0036	0.00366	CcSEcCtD
Telbivudine—Cramp muscle—Etoposide—uterine cancer	0.00359	0.00366	CcSEcCtD
Telbivudine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.00364	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00352	0.00358	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00349	0.00355	CcSEcCtD
Telbivudine—Insomnia—Progesterone—uterine cancer	0.00347	0.00353	CcSEcCtD
Telbivudine—Paraesthesia—Progesterone—uterine cancer	0.00344	0.0035	CcSEcCtD
Telbivudine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00341	0.00347	CcSEcCtD
Telbivudine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.0034	0.00346	CcSEcCtD
Telbivudine—Dyspepsia—Progesterone—uterine cancer	0.00337	0.00343	CcSEcCtD
Telbivudine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00337	0.00343	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00331	0.00337	CcSEcCtD
Telbivudine—Fatigue—Progesterone—uterine cancer	0.0033	0.00336	CcSEcCtD
Telbivudine—Pain—Progesterone—uterine cancer	0.00328	0.00334	CcSEcCtD
Telbivudine—Neutropenia—Etoposide—uterine cancer	0.00322	0.00328	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00316	0.00322	CcSEcCtD
Telbivudine—Feeling abnormal—Progesterone—uterine cancer	0.00316	0.00322	CcSEcCtD
Telbivudine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.0032	CcSEcCtD
Telbivudine—Gastrointestinal pain—Progesterone—uterine cancer	0.00313	0.00319	CcSEcCtD
Telbivudine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00312	0.00317	CcSEcCtD
Telbivudine—Neck pain—Epirubicin—uterine cancer	0.00312	0.00317	CcSEcCtD
Telbivudine—Musculoskeletal pain—Epirubicin—uterine cancer	0.00312	0.00317	CcSEcCtD
Telbivudine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00308	0.00314	CcSEcCtD
Telbivudine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00306	0.00311	CcSEcCtD
Telbivudine—Abdominal pain—Progesterone—uterine cancer	0.00303	0.00308	CcSEcCtD
Telbivudine—Body temperature increased—Progesterone—uterine cancer	0.00303	0.00308	CcSEcCtD
Telbivudine—Renal failure—Etoposide—uterine cancer	0.00302	0.00308	CcSEcCtD
Telbivudine—Neuropathy peripheral—Etoposide—uterine cancer	0.00301	0.00307	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.003	0.00305	CcSEcCtD
Telbivudine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00299	0.00305	CcSEcCtD
Telbivudine—Malaise—Dactinomycin—uterine cancer	0.00299	0.00305	CcSEcCtD
Telbivudine—Influenza like illness—Epirubicin—uterine cancer	0.00299	0.00305	CcSEcCtD
Telbivudine—Hepatobiliary disease—Etoposide—uterine cancer	0.00291	0.00296	CcSEcCtD
Telbivudine—Neck pain—Doxorubicin—uterine cancer	0.00289	0.00294	CcSEcCtD
Telbivudine—Musculoskeletal pain—Doxorubicin—uterine cancer	0.00289	0.00294	CcSEcCtD
Telbivudine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00286	0.00291	CcSEcCtD
Telbivudine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00289	CcSEcCtD
Telbivudine—Myalgia—Dactinomycin—uterine cancer	0.00283	0.00288	CcSEcCtD
Telbivudine—Discomfort—Dactinomycin—uterine cancer	0.00279	0.00284	CcSEcCtD
Telbivudine—Influenza like illness—Doxorubicin—uterine cancer	0.00277	0.00282	CcSEcCtD
Telbivudine—Asthenia—Progesterone—uterine cancer	0.00275	0.0028	CcSEcCtD
Telbivudine—Hypoaesthesia—Etoposide—uterine cancer	0.00275	0.0028	CcSEcCtD
Telbivudine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00275	0.00279	CcSEcCtD
Telbivudine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00275	0.00279	CcSEcCtD
Telbivudine—Pruritus—Progesterone—uterine cancer	0.00271	0.00276	CcSEcCtD
Telbivudine—Sepsis—Epirubicin—uterine cancer	0.00267	0.00272	CcSEcCtD
Telbivudine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00265	0.0027	CcSEcCtD
Telbivudine—Diarrhoea—Progesterone—uterine cancer	0.00262	0.00267	CcSEcCtD
Telbivudine—Dizziness—Progesterone—uterine cancer	0.00253	0.00258	CcSEcCtD
Telbivudine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00249	0.00254	CcSEcCtD
Telbivudine—Mediastinal disorder—Etoposide—uterine cancer	0.00249	0.00253	CcSEcCtD
Telbivudine—Sepsis—Doxorubicin—uterine cancer	0.00247	0.00252	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00247	0.00251	CcSEcCtD
Telbivudine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00246	0.0025	CcSEcCtD
Telbivudine—Vomiting—Progesterone—uterine cancer	0.00244	0.00248	CcSEcCtD
Telbivudine—Rash—Progesterone—uterine cancer	0.00242	0.00246	CcSEcCtD
Telbivudine—Dermatitis—Progesterone—uterine cancer	0.00241	0.00246	CcSEcCtD
Telbivudine—Headache—Progesterone—uterine cancer	0.0024	0.00244	CcSEcCtD
Telbivudine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.00242	CcSEcCtD
Telbivudine—Dysgeusia—Etoposide—uterine cancer	0.00235	0.00239	CcSEcCtD
Telbivudine—Renal impairment—Epirubicin—uterine cancer	0.00235	0.00239	CcSEcCtD
Telbivudine—Fatigue—Dactinomycin—uterine cancer	0.00234	0.00238	CcSEcCtD
Telbivudine—Back pain—Etoposide—uterine cancer	0.00232	0.00237	CcSEcCtD
Telbivudine—Pain—Dactinomycin—uterine cancer	0.00232	0.00236	CcSEcCtD
Telbivudine—Muscle spasms—Etoposide—uterine cancer	0.00231	0.00235	CcSEcCtD
Telbivudine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.00234	CcSEcCtD
Telbivudine—Nausea—Progesterone—uterine cancer	0.00228	0.00232	CcSEcCtD
Telbivudine—Pain in extremity—Epirubicin—uterine cancer	0.00224	0.00228	CcSEcCtD
Telbivudine—Feeling abnormal—Dactinomycin—uterine cancer	0.00223	0.00227	CcSEcCtD
Telbivudine—Ill-defined disorder—Etoposide—uterine cancer	0.00223	0.00227	CcSEcCtD
Telbivudine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00222	0.00226	CcSEcCtD
Telbivudine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.00225	CcSEcCtD
Telbivudine—Migraine—Epirubicin—uterine cancer	0.0022	0.00224	CcSEcCtD
Telbivudine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00223	CcSEcCtD
Telbivudine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00223	CcSEcCtD
Telbivudine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00218	0.00221	CcSEcCtD
Telbivudine—Renal impairment—Doxorubicin—uterine cancer	0.00217	0.00221	CcSEcCtD
Telbivudine—Malaise—Etoposide—uterine cancer	0.00217	0.00221	CcSEcCtD
Telbivudine—Abdominal pain—Dactinomycin—uterine cancer	0.00214	0.00218	CcSEcCtD
Telbivudine—Body temperature increased—Dactinomycin—uterine cancer	0.00214	0.00218	CcSEcCtD
Telbivudine—Cough—Etoposide—uterine cancer	0.0021	0.00213	CcSEcCtD
Telbivudine—Pain in extremity—Doxorubicin—uterine cancer	0.00207	0.00211	CcSEcCtD
Telbivudine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.0021	CcSEcCtD
Telbivudine—Chest pain—Etoposide—uterine cancer	0.00205	0.00208	CcSEcCtD
Telbivudine—Abdominal pain upper—Epirubicin—uterine cancer	0.00204	0.00208	CcSEcCtD
Telbivudine—Migraine—Doxorubicin—uterine cancer	0.00204	0.00207	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00203	0.00207	CcSEcCtD
Telbivudine—Discomfort—Etoposide—uterine cancer	0.00202	0.00206	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00201	0.00205	CcSEcCtD
Telbivudine—Nasopharyngitis—Epirubicin—uterine cancer	0.002	0.00204	CcSEcCtD
Telbivudine—Gastritis—Epirubicin—uterine cancer	0.00198	0.00201	CcSEcCtD
Telbivudine—Muscular weakness—Epirubicin—uterine cancer	0.00197	0.00201	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00197	0.00201	CcSEcCtD
Telbivudine—Abdominal distension—Epirubicin—uterine cancer	0.00195	0.00198	CcSEcCtD
Telbivudine—Asthenia—Dactinomycin—uterine cancer	0.00194	0.00198	CcSEcCtD
Telbivudine—Influenza—Epirubicin—uterine cancer	0.00193	0.00197	CcSEcCtD
Telbivudine—Thrombocytopenia—Etoposide—uterine cancer	0.00192	0.00195	CcSEcCtD
Telbivudine—Skin disorder—Etoposide—uterine cancer	0.0019	0.00194	CcSEcCtD
Telbivudine—Abdominal pain upper—Doxorubicin—uterine cancer	0.00189	0.00192	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00186	0.0019	CcSEcCtD
Telbivudine—Diarrhoea—Dactinomycin—uterine cancer	0.00185	0.00189	CcSEcCtD
Telbivudine—Nasopharyngitis—Doxorubicin—uterine cancer	0.00185	0.00188	CcSEcCtD
Telbivudine—Gastritis—Doxorubicin—uterine cancer	0.00183	0.00186	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00183	0.00186	CcSEcCtD
Telbivudine—Muscular weakness—Doxorubicin—uterine cancer	0.00183	0.00186	CcSEcCtD
Telbivudine—Neutropenia—Epirubicin—uterine cancer	0.00181	0.00184	CcSEcCtD
Telbivudine—Abdominal distension—Doxorubicin—uterine cancer	0.0018	0.00183	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.0018	0.00183	CcSEcCtD
Telbivudine—Influenza—Doxorubicin—uterine cancer	0.00179	0.00182	CcSEcCtD
Telbivudine—Paraesthesia—Etoposide—uterine cancer	0.00176	0.00179	CcSEcCtD
Telbivudine—Vomiting—Dactinomycin—uterine cancer	0.00172	0.00175	CcSEcCtD
Telbivudine—Rash—Dactinomycin—uterine cancer	0.00171	0.00174	CcSEcCtD
Telbivudine—Renal failure—Epirubicin—uterine cancer	0.00169	0.00172	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00169	0.00172	CcSEcCtD
Telbivudine—Fatigue—Etoposide—uterine cancer	0.00169	0.00172	CcSEcCtD
Telbivudine—Neuropathy peripheral—Epirubicin—uterine cancer	0.00169	0.00172	CcSEcCtD
Telbivudine—Pain—Etoposide—uterine cancer	0.00168	0.00171	CcSEcCtD
Telbivudine—Neutropenia—Doxorubicin—uterine cancer	0.00167	0.0017	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00166	0.00169	CcSEcCtD
Telbivudine—Hepatobiliary disease—Epirubicin—uterine cancer	0.00163	0.00166	CcSEcCtD
Telbivudine—Feeling abnormal—Etoposide—uterine cancer	0.00162	0.00164	CcSEcCtD
Telbivudine—Nausea—Dactinomycin—uterine cancer	0.00161	0.00164	CcSEcCtD
Telbivudine—Gastrointestinal pain—Etoposide—uterine cancer	0.0016	0.00163	CcSEcCtD
Telbivudine—Renal failure—Doxorubicin—uterine cancer	0.00157	0.0016	CcSEcCtD
Telbivudine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00156	0.00159	CcSEcCtD
Telbivudine—Abdominal pain—Etoposide—uterine cancer	0.00155	0.00158	CcSEcCtD
Telbivudine—Body temperature increased—Etoposide—uterine cancer	0.00155	0.00158	CcSEcCtD
Telbivudine—Hepatitis—Epirubicin—uterine cancer	0.00155	0.00157	CcSEcCtD
Telbivudine—Hypoaesthesia—Epirubicin—uterine cancer	0.00154	0.00157	CcSEcCtD
Telbivudine—Pharyngitis—Epirubicin—uterine cancer	0.00154	0.00156	CcSEcCtD
Telbivudine—Connective tissue disorder—Epirubicin—uterine cancer	0.00152	0.00155	CcSEcCtD
Telbivudine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00151	0.00154	CcSEcCtD
Telbivudine—Hepatitis—Doxorubicin—uterine cancer	0.00143	0.00146	CcSEcCtD
Telbivudine—Hypoaesthesia—Doxorubicin—uterine cancer	0.00142	0.00145	CcSEcCtD
Telbivudine—Pharyngitis—Doxorubicin—uterine cancer	0.00142	0.00145	CcSEcCtD
Telbivudine—Asthenia—Etoposide—uterine cancer	0.00141	0.00143	CcSEcCtD
Telbivudine—Connective tissue disorder—Doxorubicin—uterine cancer	0.00141	0.00143	CcSEcCtD
Telbivudine—Mediastinal disorder—Epirubicin—uterine cancer	0.00139	0.00142	CcSEcCtD
Telbivudine—Pruritus—Etoposide—uterine cancer	0.00139	0.00141	CcSEcCtD
Telbivudine—Malnutrition—Epirubicin—uterine cancer	0.00135	0.00137	CcSEcCtD
Telbivudine—Diarrhoea—Etoposide—uterine cancer	0.00134	0.00137	CcSEcCtD
Telbivudine—Dysgeusia—Epirubicin—uterine cancer	0.00132	0.00134	CcSEcCtD
Telbivudine—Back pain—Epirubicin—uterine cancer	0.0013	0.00133	CcSEcCtD
Telbivudine—Dizziness—Etoposide—uterine cancer	0.0013	0.00132	CcSEcCtD
Telbivudine—Muscle spasms—Epirubicin—uterine cancer	0.00129	0.00132	CcSEcCtD
Telbivudine—Mediastinal disorder—Doxorubicin—uterine cancer	0.00129	0.00131	CcSEcCtD
Telbivudine—Ill-defined disorder—Epirubicin—uterine cancer	0.00125	0.00127	CcSEcCtD
Telbivudine—Vomiting—Etoposide—uterine cancer	0.00125	0.00127	CcSEcCtD
Telbivudine—Malnutrition—Doxorubicin—uterine cancer	0.00125	0.00127	CcSEcCtD
Telbivudine—Rash—Etoposide—uterine cancer	0.00124	0.00126	CcSEcCtD
Telbivudine—Dermatitis—Etoposide—uterine cancer	0.00124	0.00126	CcSEcCtD
Telbivudine—Headache—Etoposide—uterine cancer	0.00123	0.00125	CcSEcCtD
Telbivudine—Dysgeusia—Doxorubicin—uterine cancer	0.00122	0.00124	CcSEcCtD
Telbivudine—Malaise—Epirubicin—uterine cancer	0.00121	0.00124	CcSEcCtD
Telbivudine—Back pain—Doxorubicin—uterine cancer	0.00121	0.00123	CcSEcCtD
Telbivudine—Muscle spasms—Doxorubicin—uterine cancer	0.0012	0.00122	CcSEcCtD
Telbivudine—Cough—Epirubicin—uterine cancer	0.00118	0.0012	CcSEcCtD
Telbivudine—Nausea—Etoposide—uterine cancer	0.00116	0.00119	CcSEcCtD
Telbivudine—Ill-defined disorder—Doxorubicin—uterine cancer	0.00116	0.00118	CcSEcCtD
Telbivudine—Arthralgia—Epirubicin—uterine cancer	0.00115	0.00117	CcSEcCtD
Telbivudine—Chest pain—Epirubicin—uterine cancer	0.00115	0.00117	CcSEcCtD
Telbivudine—Myalgia—Epirubicin—uterine cancer	0.00115	0.00117	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00114	0.00116	CcSEcCtD
Telbivudine—Discomfort—Epirubicin—uterine cancer	0.00113	0.00115	CcSEcCtD
Telbivudine—Malaise—Doxorubicin—uterine cancer	0.00112	0.00114	CcSEcCtD
Telbivudine—Cough—Doxorubicin—uterine cancer	0.00109	0.00111	CcSEcCtD
Telbivudine—Nervous system disorder—Epirubicin—uterine cancer	0.00108	0.0011	CcSEcCtD
Telbivudine—Thrombocytopenia—Epirubicin—uterine cancer	0.00108	0.0011	CcSEcCtD
Telbivudine—Skin disorder—Epirubicin—uterine cancer	0.00107	0.00109	CcSEcCtD
Telbivudine—Myalgia—Doxorubicin—uterine cancer	0.00106	0.00108	CcSEcCtD
Telbivudine—Arthralgia—Doxorubicin—uterine cancer	0.00106	0.00108	CcSEcCtD
Telbivudine—Chest pain—Doxorubicin—uterine cancer	0.00106	0.00108	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00105	0.00107	CcSEcCtD
Telbivudine—Discomfort—Doxorubicin—uterine cancer	0.00105	0.00107	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.001	0.00102	CcSEcCtD
Telbivudine—Nervous system disorder—Doxorubicin—uterine cancer	0.000997	0.00102	CcSEcCtD
Telbivudine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000996	0.00101	CcSEcCtD
Telbivudine—Insomnia—Epirubicin—uterine cancer	0.000994	0.00101	CcSEcCtD
Telbivudine—Skin disorder—Doxorubicin—uterine cancer	0.000988	0.00101	CcSEcCtD
Telbivudine—Paraesthesia—Epirubicin—uterine cancer	0.000987	0.001	CcSEcCtD
Telbivudine—Dyspepsia—Epirubicin—uterine cancer	0.000968	0.000985	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000949	0.000966	CcSEcCtD
Telbivudine—Fatigue—Epirubicin—uterine cancer	0.000948	0.000965	CcSEcCtD
Telbivudine—Pain—Epirubicin—uterine cancer	0.00094	0.000957	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000927	0.000943	CcSEcCtD
Telbivudine—Insomnia—Doxorubicin—uterine cancer	0.00092	0.000936	CcSEcCtD
Telbivudine—Paraesthesia—Doxorubicin—uterine cancer	0.000913	0.00093	CcSEcCtD
Telbivudine—Feeling abnormal—Epirubicin—uterine cancer	0.000906	0.000922	CcSEcCtD
Telbivudine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000899	0.000915	CcSEcCtD
Telbivudine—Dyspepsia—Doxorubicin—uterine cancer	0.000895	0.000911	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000878	0.000894	CcSEcCtD
Telbivudine—Fatigue—Doxorubicin—uterine cancer	0.000877	0.000893	CcSEcCtD
Telbivudine—Pain—Doxorubicin—uterine cancer	0.00087	0.000885	CcSEcCtD
Telbivudine—Abdominal pain—Epirubicin—uterine cancer	0.000869	0.000884	CcSEcCtD
Telbivudine—Body temperature increased—Epirubicin—uterine cancer	0.000869	0.000884	CcSEcCtD
Telbivudine—Feeling abnormal—Doxorubicin—uterine cancer	0.000838	0.000853	CcSEcCtD
Telbivudine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000832	0.000847	CcSEcCtD
Telbivudine—Abdominal pain—Doxorubicin—uterine cancer	0.000804	0.000818	CcSEcCtD
Telbivudine—Body temperature increased—Doxorubicin—uterine cancer	0.000804	0.000818	CcSEcCtD
Telbivudine—Asthenia—Epirubicin—uterine cancer	0.000789	0.000803	CcSEcCtD
Telbivudine—Pruritus—Epirubicin—uterine cancer	0.000778	0.000792	CcSEcCtD
Telbivudine—Diarrhoea—Epirubicin—uterine cancer	0.000752	0.000766	CcSEcCtD
Telbivudine—Asthenia—Doxorubicin—uterine cancer	0.00073	0.000743	CcSEcCtD
Telbivudine—Dizziness—Epirubicin—uterine cancer	0.000727	0.00074	CcSEcCtD
Telbivudine—Pruritus—Doxorubicin—uterine cancer	0.00072	0.000732	CcSEcCtD
Telbivudine—Vomiting—Epirubicin—uterine cancer	0.000699	0.000711	CcSEcCtD
Telbivudine—Diarrhoea—Doxorubicin—uterine cancer	0.000696	0.000708	CcSEcCtD
Telbivudine—Rash—Epirubicin—uterine cancer	0.000693	0.000705	CcSEcCtD
Telbivudine—Dermatitis—Epirubicin—uterine cancer	0.000692	0.000705	CcSEcCtD
Telbivudine—Headache—Epirubicin—uterine cancer	0.000689	0.000701	CcSEcCtD
Telbivudine—Dizziness—Doxorubicin—uterine cancer	0.000673	0.000685	CcSEcCtD
Telbivudine—Nausea—Epirubicin—uterine cancer	0.000653	0.000665	CcSEcCtD
Telbivudine—Vomiting—Doxorubicin—uterine cancer	0.000647	0.000658	CcSEcCtD
Telbivudine—Rash—Doxorubicin—uterine cancer	0.000641	0.000653	CcSEcCtD
Telbivudine—Dermatitis—Doxorubicin—uterine cancer	0.000641	0.000652	CcSEcCtD
Telbivudine—Headache—Doxorubicin—uterine cancer	0.000637	0.000649	CcSEcCtD
Telbivudine—Nausea—Doxorubicin—uterine cancer	0.000604	0.000615	CcSEcCtD
